Cambria Investment Management, L.P. Jazz Pharmaceuticals PLC Transaction History
Cambria Investment Management, L.P.
- $1.59 Billion
- Q3 2024
A detailed history of Cambria Investment Management, L.P. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cambria Investment Management, L.P. holds 4,154 shares of JAZZ stock, worth $511,565. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,154
Previous 3,840
8.18%
Holding current value
$511,565
Previous $409,000
13.2%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$757 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$752 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$307 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$259 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$240 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.72B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...